|
1
|
Braun J and Sieper J: Ankylosing
spondylitis. Lancet. 369:1379–1390. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhu W, He X, Cheng K, Zhang L, Chen D,
Wang X, Qiu G, Cao X and Weng X: Ankylosing spondylitis: Etiology,
pathogenesis, and treatments. Bone Res. 7(22)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Smith JA: Update on ankylosing
spondylitis: Current concepts in pathogenesis. Curr Allergy Asthma
Rep. 15(489)2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vanaki N, Aslani S, Jamshidi A and
Mahmoudi M: Role of innate immune system in the pathogenesis of
ankylosing spondylitis. Biomed Pharmacother. 105:130–143.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gracey E, Qaiyum Z, Almaghlouth I, Lawson
D, Karki S, Avvaru N, Zhang Z, Yao Y, Ranganathan V, Baglaenko Y
and Inman RD: IL-7 primes IL-17 in mucosal-associated invariant T
(MAIT) cells, which contribute to the Th17-axis in ankylosing
spondylitis. Ann Rheum Dis. 75:2124–2132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ranganathan V, Gracey E, Brown MA, Inman
RD and Haroon N: Pathogenesis of ankylosing spondylitis-recent
advances and future directions. Nat Rev Rheumatol. 13:359–367.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Moschen AR, Tilg H and Raine T: IL-12,
IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting.
Nat Rev Gastroenterol Hepatol. 16:185–196. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gaffen SL, Jain R, Garg AV and Cua DJ: The
IL-23-IL-17 immune axis: From mechanisms to therapeutic testing.
Nat Rev Immunol. 14:585–600. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Barakat W, Safwet N, El-Maraghy NN and
Zakaria MN: Candesartan and glycyrrhizin ameliorate ischemic brain
damage through downregulation of the TLR signaling cascade. Eur J
Pharmacol. 724:43–50. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Williams AJ, Dave JR and Tortella FC:
Neuroprotection with the proteasome inhibitor MLN519 in focal
ischemic brain injury: Relation to nuclear factor kappaB
(NF-kappaB), inflammatory gene expression, and leukocyte
infiltration. Neurochem Int. 49:106–112. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ghoreschi K, Laurence A and O'Shea JJ:
Janus kinases in immune cell signaling. Immunol Rev. 228:273–287.
2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Feng X, Yang Q, Wang C, Tong W and Xu W:
Punicalagin exerts protective effects against ankylosing
spondylitis by regulating NF-κB-TH17/JAK2/STAT3 signaling and
oxidative stress. Biomed Res Int. 2020(4918239)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Parham C, Chirica M, Timans J, Vaisberg E,
Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, et al: A
receptor for the heterodimeric cytokine IL-23 is composed of
IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J
Immunol. 168:5699–5708. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
MacFarlane LA, Arant KR, Kostic AM, Mass
H, Jones MH, Collins JE, Losina E and Katz JN: Identifying
inflammation in knee osteoarthritis: relationship of synovial fluid
white blood cell count to effusion-synovitis on magnetic resonance
imaging. Arthritis Care Res (Hoboken): Oct 17, 2022 (Epub ahead of
print).
|
|
15
|
Liu L, Chen H, Jiang T and He D:
MicroRNA-106b overexpression suppresses synovial inflammation and
alleviates synovial damage in patients with rheumatoid arthritis.
Mod Rheumatol. 32:1054–1063. 2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Garrido-Mesa J and Brown MA: T cell
repertoire profiling and the mechanism by which HLA-B27 causes
ankylosing spondylitis. Curr Rheumatol Rep. 24:398–410.
2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shah NG, Keraliya A, Nunez DB, Schoenfeld
A, Harris MB, Bono CM and Khurana B: Injuries to the rigid spine:
What the spine surgeon wants to know. Radiographics. 39:449–466.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gouveia EB, Elmann D and Morales MS:
Ankylosing spondylitis and uveitis: Overview. Rev Bras Reumatol.
52:742–756. 2012.PubMed/NCBI
|
|
19
|
Wang M, Wang L, Zhang X, Yang X, Li X, Xia
Q, Chen M, Han R, Liu R, Xu S and Pan F: Overexpression of miR-31
in peripheral blood mononuclear cells (PBMC) from patients with
ankylosing spondylitis. Med Sci Monit. 23:5488–5494.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tang Y, Wang B, Sun X, Li H, Ouyang X, Wei
J, Dai B, Zhang Y and Li X: Rheumatoid arthritis fibroblast-like
synoviocytes co-cultured with PBMC increased peripheral
CD4+ CXCR5+ ICOS+ T cell numbers.
Clin Exp Immunol. 190:384–393. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang JX, Jing FY, Xu YC, Zong HX, Chu YR,
Wang C, Chen KM, Tong WQ, Wang XL and Xu SQ: The potential
regulatory mechanism of lncRNA 122K13.12 and lncRNA 326C3.7 in
ankylosing spondylitis. Front Mol Biosci. 8(745441)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
van der Linden S, Valkenburg HA and Cats
A: Evaluation of diagnostic criteria for ankylosing spondylitis. A
proposal for modification of the New York criteria. Arthritis
Rheum. 27:361–368. 1984.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shiau MY, Lo MK, Chang CP, Yang TP, Ho KT
and Chang YH: Association of tumour necrosis factor alpha promoter
polymorphisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis.
66:562–563. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hu Y, Chen X, Wang S, Jing Y and Su J:
Subchondral bone microenvironment in osteoarthritis and pain. Bone
Res. 9(20)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tam LS, Chan KY and Li EK: The influence
of illness and variables associated with functional limitations in
Chinese patients with ankylosing spondylitis. J Rheumatol.
34:1032–1039. 2007.PubMed/NCBI
|
|
27
|
Gu X, Wu H and Fu P: Allicin attenuates
inflammation and suppresses HLA-B27 protein expression in
ankylosing spondylitis mice. Biomed Res Int.
2013(171573)2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hu Y, Li X, Zhi X, Cong W, Huang B, Chen
H, Wang Y, Li Y, Wang L, Fang C, et al: RANKL from bone marrow
adipose lineage cells promotes osteoclast formation and bone loss.
EMBO Rep. 22(e52481)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen X, Zhi X, Wang J and Su J: RANKL
signaling in bone marrow mesenchymal stem cells negatively
regulates osteoblastic bone formation. Bone Res.
6(34)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen XX, Baum W, Dwyer D, Stock M, Schwabe
K, Ke HZ, Stolina M, Schett G and Bozec A: Sclerostin inhibition
reverses systemic, periarticular and local bone loss in arthritis.
Ann Rheum Dis. 72:1732–1736. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Aune TM and Spurlock CF III: Long
non-coding RNAs in innate and adaptive immunity. Virus Res.
212:146–160. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lan X, Ma H, Zhang Z, Ye D, Min J, Cai F
and Luo J: Downregulation of lncRNA TUG1 is involved in ankylosing
spondylitis and is related to disease activity and course of
treatment. Biosci Trends. 12:389–394. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li Y, Zhang S, Zhang C and Wang M: LncRNA
MEG3 inhibits the inflammatory response of ankylosing spondylitis
by targeting miR-146a. Mol Cell Biochem. 466:17–24. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gong ZM, Tang ZY and Sun XL: LncRNA PRNCR1
regulates CXCR4 expression to affect osteogenic differentiation and
contribute to osteolysis after hip replacement. Gene. 673:251–261.
2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wielińska J, Świerkot J, Kolossa K, Bugaj
B, Chaszczewska-Markowska M, Jeka S and Bogunia-Kubik K:
Polymorphisms within genes coding for IL-17A and F and their
receptor as clinical hallmarks in ankylosing spondylitis. Mediators
Inflamm. 2021(3125922)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liao HT, Lin YF, Tsai CY and Chou CT:
Regulatory T cells in ankylosing spondylitis and the response after
adalimumab treatment. Joint Bone Spine. 82:423–427. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang H, Sun N, Li K, Tian J and Li J:
Assay of peripheral regulatory Vδ1 T cells in ankylosing
spondylitis and its significance. Med Sci Monit. 22:3163–3168.
2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hreggvidsdottir HS, Noordenbos T and
Baeten DL: Inflammatory pathways in spondyloarthritis. Mol Immunol.
57:28–37. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Arora D and Robey PG: Recent updates on
the biological basis of heterogeneity in bone marrow stromal
cells/skeletal stem cells. Biomater Transl. 3:3–16. 2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hammitzsch A, Chen L, de Wit J, Al-Mossawi
MH, Ridley A, Sekine T, Simone D, Doig K, Skapenko A and Bowness P:
Inhibiting ex-vivo Th17 responses in ankylosing spondylitis by
targeting Janus kinases. Sci Rep. 8(15645)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Klasen C, Meyer A, Wittekind PS, Waqué I,
Nabhani S and Kofler DM: Prostaglandin receptor EP4 expression by
Th17 cells is associated with high disease activity in ankylosing
spondylitis. Arthritis Res Ther. 21(159)2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Dong C: TH17 cells in development: An
updated view of their molecular identity and genetic programming.
Nat Rev Immunol. 8:337–348. 2008.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Raychaudhuri SP and Raychaudhuri SK:
IL-23/IL-17 axis in spondyloarthritis-bench to bedside. Clin
Rheumatol. 35:1437–1441. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Melis L, Vandooren B, Kruithof E, Jacques
P, De Vos M, Mielants H, Verbruggen G, De Keyser F and Elewaut D:
Systemic levels of IL-23 are strongly associated with disease
activity in rheumatoid arthritis but not spondyloarthritis. Ann
Rheum Dis. 69:618–623. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Raychaudhuri SK and Raychaudhuri SP: Janus
kinase/signal transducer and activator of transcription pathways in
spondyloarthritis. Curr Opin Rheumatol. 29:311–316. 2017.PubMed/NCBI View Article : Google Scholar
|
